Sun, Y., Yang, H., Lou, H., Wang, J., Wu, X., Li, D., Tao, W., Zhang, H., Wang, K., Li, Y., Wang, C., Li, G., Wang, Y., Li, D., Cai, H., Pan, M., Tang, Y., Liu, T., Xia, Y. (2025). Cadonilimab plus platinum-based chemotherapy ± bevacizumab for persistent, recurrent, or metastatic cervical cancer: Subgroup analyses of COMPASSION-16.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5509